Clemastine: Antihistamine for Respiratory Relief | MolForge

What is Clemastine?

Clemastine is a first-generation antihistamine medication primarily used to alleviate symptoms associated with allergic reactions. As a member of the ethanolamine class of antihistamines, it is known for its effectiveness in treating conditions like allergic rhinitis (hay fever) and urticaria (hives). It works by blocking the action of histamine, a natural substance released by the body during an allergic response. Clemastine is available in both generic forms and under various brand names, with clemastine fumarate being the most common salt form. It is often prescribed for temporary relief of symptoms such as sneezing, runny nose, itchy or watery eyes, and itching of the nose or throat. While effective, its first-generation status means it can cause drowsiness, a characteristic shared by many older antihistamines.

Generic clemastine is widely available, offering a more affordable option for patients. Brand names commonly associated with clemastine include Tavist, Tavist-1, and Aller-Clenil, though availability may vary by region and country. The fumarate salt form is typically used in oral formulations, such as tablets and syrups, making it convenient for self-administration.

Mechanism of Action

Clemastine exerts its therapeutic effects by acting as a potent and selective antagonist of the histamine H1 receptor. Histamine is a key mediator in the inflammatory and allergic response. When the body encounters an allergen, mast cells and basophils release histamine. This histamine then binds to H1 receptors located on various cells, including those in the smooth muscle, vascular endothelium, and central nervous system. This binding triggers a cascade of events leading to the characteristic symptoms of an allergic reaction:

• Vasodilation and Increased Vascular Permeability: Histamine binding causes blood vessels to widen and become more permeable, leading to redness, swelling (edema), and fluid leakage, which contributes to nasal congestion and hives.
• Smooth Muscle Contraction: It can cause contraction of smooth muscles, such as those in the bronchi, potentially leading to bronchoconstriction (though less pronounced with clemastine than with severe histamine release).
• Nerve Stimulation: Histamine stimulates sensory nerve endings, causing itching (pruritus) and sneezing.
• Central Nervous System Effects: H1 receptors are also present in the brain. Histamine plays a role in wakefulness and alertness.

Clemastine competitively inhibits histamine from binding to these H1 receptors. By occupying the receptor sites, clemastine prevents histamine from activating them, thereby blocking or reducing the downstream effects. This antagonism leads to a reduction in:

• Runny nose (rhinorrhea)
• Sneezing
• Itching (pruritus)
• Watery eyes (lacrimation)
• Skin redness and swelling (urticaria)

Furthermore, as a first-generation antihistamine, clemastine possesses significant lipophilicity, allowing it to readily cross the blood-brain barrier. This property contributes to its central nervous system effects, most notably sedation and drowsiness, as it also antagonizes H1 receptors in the brain, influencing the sleep-wake cycle. While this central effect can be a drawback, it is a defining characteristic of first-generation antihistamines like clemastine.

Clinical Uses & Indications

Clemastine is primarily indicated for the symptomatic relief of conditions caused by the release of histamine during allergic reactions. Its efficacy stems from its ability to block H1 receptors, thereby mitigating the inflammatory and hypersensitivity responses.

FDA-Approved Uses:

The U.S. Food and Drug Administration (FDA) has approved clemastine for the following indications:

• Allergic Rhinitis: This includes seasonal allergic rhinitis (hay fever) and perennial allergic rhinitis. Symptoms commonly treated include sneezing, rhinorrhea, nasal pruritus, and ocular symptoms such as itching and watering of the eyes.
• Urticaria (Hives): Clemastine is effective in reducing the itching, redness, and swelling associated with acute and chronic urticaria. It helps to alleviate the discomfort and appearance of hives.

Off-Label Uses:

While not officially FDA-approved, clemastine may be used off-label by clinicians for other conditions where histamine plays a role or where its anticholinergic properties might be beneficial, although these uses are less common and should be based on professional medical judgment.

It's important to note that clemastine provides symptomatic relief and does not cure the underlying allergic condition. Patients are advised to use it as needed during periods of allergic exacerbation. The choice of clemastine over other antihistamines often depends on the specific symptoms, patient history, potential for side effects, and the need for sedation.

Dosage & Administration

The dosage and administration of clemastine are crucial for ensuring both efficacy and safety. Dosing typically depends on the age of the patient, the severity of the condition being treated, and the specific formulation used. It is generally recommended to take clemastine with food or milk to minimize potential gastrointestinal upset.

Common Dosage Forms:

• Tablets: Oral tablets are the most common form, typically containing 2.68 mg of clemastine fumarate (equivalent to 2 mg clemastine base).
• Syrup/Oral Solution: Liquid formulations are often available, particularly for pediatric use or for individuals who have difficulty swallowing tablets. The concentration typically is 0.67 mg of clemastine fumarate per mL (equivalent to 0.5 mg clemastine base per mL).

Typical Dosing Regimens:

Dosages are usually expressed in terms of clemastine fumarate. Always follow the specific instructions provided by a healthcare professional or the product labeling.

• Adults and Children 12 years and older: The usual starting dose is 1.34 mg to 2.68 mg (one-half to one tablet or 5 mL to 10 mL of syrup) taken twice daily. In some cases, the dose may be increased to 5.36 mg per day if needed, divided into two doses.
• Children 6 to 12 years: The recommended dose is typically 1.34 mg (one-half tablet or 5 mL of syrup) twice daily.
• Children under 6 years: Dosing for younger children should be determined by a healthcare provider, often based on weight. The liquid formulation is generally preferred for this age group.

Administration Instructions:

• Take the medication at the same time(s) each day.
• If a dose is missed, take it as soon as remembered unless it is close to the time for the next dose. In that case, skip the missed dose and resume the regular dosing schedule. Do not double the dose.
• Store clemastine at room temperature, away from heat and moisture.
• Consult a healthcare provider if symptoms do not improve or worsen after a specified period (e.g., one week for allergic symptoms).

Important Note: Due to its potential to cause drowsiness, patients should exercise caution when driving or operating heavy machinery after taking clemastine. Alcohol consumption should be minimized as it can potentiate the sedative effects.

Side Effects & Safety

Like all medications, clemastine can cause side effects, ranging from common and mild to rare but serious. Understanding these potential adverse effects is crucial for safe and effective use.

Common Side Effects:

The most frequently reported side effects of clemastine are related to its central nervous system effects and anticholinergic properties:

• Drowsiness/Sedation: This is the most common side effect, often significant due to clemastine being a first-generation antihistamine.
• Dry Mouth, Nose, and Throat: Anticholinergic effects can reduce secretions.
• Dizziness: Feeling lightheaded or unsteady.
• Headache: Mild to moderate head pain.
• Nausea or Vomiting: Gastrointestinal discomfort.
• Constipation: Reduced bowel motility.
• Blurred Vision: Due to anticholinergic effects on the eyes.

Serious Side Effects:

While less common, certain side effects require immediate medical attention:

• Paradoxical Excitation: In some individuals, particularly children, antihistamines can cause hyperactivity, nervousness, or insomnia instead of drowsiness.
• Urinary Retention: Difficulty or inability to urinate, especially in older men with prostate issues.
• Severe Drowsiness or Confusion: Particularly in the elderly.
• Tachycardia or Arrhythmias: Irregular heart rhythms.
• Seizures: Although rare, seizures can occur.

Seek medical help immediately if you experience any signs of a severe allergic reaction (anaphylaxis), such as rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, or trouble breathing.

Contraindications and Precautions:

Clemastine is contraindicated in patients with:

• Hypersensitivity: Known allergy to clemastine or other antihistamines of the ethanolamine class.
• Asthma: Use with caution; it may thicken bronchial secretions.
• Glaucoma: Particularly narrow-angle glaucoma, due to potential increase in intraocular pressure.
• Malignant Obstruction of the GI Tract.
• Symptomatic Prostatic Hypertrophy.
• Bladder Neck Obstruction.
• Use in Newborns and Premature Infants: Generally not recommended.
• MAOI Inhibitors: Concurrent use is contraindicated (see Drug Interactions).

Use with Caution: Elderly patients may be more susceptible to side effects like dizziness, sedation, and hypotension. Patients with respiratory conditions like emphysema or chronic bronchitis should use it cautiously due to potential thickening of bronchial secretions.

Drug Interactions

Clemastine can interact with other medications, potentially altering its effectiveness or increasing the risk of side effects. It is essential to inform your healthcare provider about all medications, supplements, and herbal products you are currently taking.

Notable Drug Interactions:

• Central Nervous System (CNS) Depressants: Concomitant use with alcohol, sedatives, hypnotics, tranquilizers, sleeping pills, or other CNS depressants can lead to additive sedative effects, significantly impairing alertness and performance.
• Monoamine Oxidase Inhibitors (MAOIs): MAOIs (e.g., phenelzine, tranylcypromine) prolong and intensify the anticholinergic effects of antihistamines like clemastine. Concurrent use is generally contraindicated. If a patient has been on an MAOI, at least 14 days should elapse before clemastine is administered.
• Anticholinergic Drugs: Combining clemastine with other medications possessing anticholinergic properties (e.g., certain antidepressants, antiparkinsonian agents, antispasmodics) can lead to additive anticholinergic effects, increasing the risk of dry mouth, blurred vision, constipation, urinary retention, and CNS toxicity.
• Ototoxic Drugs: Antihistamines can mask the symptoms of ototoxicity (ear damage) caused by certain drugs, such as aminoglycoside antibiotics or cisplatin.
• Enzyme Inducers/Inhibitors: While not as extensively studied for clemastine specifically compared to some other drugs, medications that induce or inhibit hepatic enzymes (like those in the cytochrome P450 system) could potentially affect clemastine metabolism, though clinical significance is often minimal for first-generation antihistamines.

Always consult with a pharmacist or physician regarding potential drug interactions before starting clemastine, especially if you are taking multiple medications.

Molecular Properties

Understanding the molecular characteristics of clemastine is fundamental to comprehending its behavior in biological systems and its pharmacokinetic profile.

Molecular Formula	C21H26ClNO3
Molecular Weight	375.89 g/mol (for clemastine base)
SMILES Notation	CN1CCCC1CCOc1ccc(cc1)C(C)(c1ccccc1)Cl
Chemical Name	2-[2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl]dimethylazetidine (This is a more specific IUPAC-derived name for one enantiomer; the provided SMILES represents the racemic mixture or a specific isomer depending on context. The SMILES notation is a linear representation of the molecular structure.)
Drug Class	Antihistamine (H1 antagonist), Ethanolamine derivative
LogP (approximate)	~4.5 - 5.0 (Indicates high lipophilicity, consistent with blood-brain barrier penetration)

Structure Description:

The SMILES string CN1CCCC1CCOc1ccc(cc1)C(C)(c1ccccc1)Cl describes a complex organic molecule. Key features include:

• A central diarylmethyl group substituted with a chlorine atom and a phenyl ring.
• An ether linkage connecting an ethyl group to this central structure.
• The ethyl group is further attached to a substituted azetidine ring (a four-membered nitrogen-containing heterocycle).
• The molecule contains chiral centers, meaning it can exist as different stereoisomers (enantiomers and diastereomers). The specific stereochemistry can influence pharmacological activity and side effect profiles.

Its high lipophilicity (indicated by a high LogP value) is a key factor contributing to its ability to cross the blood-brain barrier, leading to both its central antihistaminic effects and its prominent sedative side effect. The presence of the ether linkage and the azetidine ring are characteristic of the ethanolamine class of antihistamines.

Analyze Clemastine with MolForge

Understanding the intricate details of clemastine, from its molecular structure and interactions to its clinical applications and potential side effects, is crucial for researchers and pharmaceutical professionals. MolForge's AI-powered platform provides advanced tools to delve deeper into such molecules.

Leveraging cutting-edge artificial intelligence, MolForge allows you to explore clemastine's properties, predict its behavior, identify potential drug-target interactions, and even discover novel analogs. Whether you are investigating its pharmacokinetic profile, exploring new therapeutic indications, or optimizing its structure for reduced side effects, MolForge can accelerate your discovery process.

Ready to unlock the full potential of molecular discovery? Explore clemastine and countless other molecules with MolForge's intelligent platform today.